Doyle Thomas James Insider Trades & Stock Holdings

SVP, Finance & Accounting · Kura Oncology, Inc. · Latest filing Sep 28, 2026

Doyle Thomas James, SVP, Finance & Accounting at Kura Oncology, Inc. has 1 Form 4 trade on file since Sep 28, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($48.36K), net -$48.36K. Latest filing: disposed of 4.61K shares of $KURA on Sep 28, 2026 at $10.50.

Trades on file

1

Open-market bought

$0

Open-market sold

$48.36K

Net open-market

-$48.36K

Latest filing

Sep 28, 2026

All insider trades by Doyle Thomas James

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 28, 2026	$KURA	Sell (Open-market sale)	4.61K	$10.50	$48.36K			+0.1%			SVP, Finance & Accounting		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Doyle Thomas James traded

• $KURA

Frequently asked questions

Has Doyle Thomas James been buying or selling stock?

Doyle Thomas James has 0 open-market purchases and 1 open-market sale on file, net -$48.36K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Doyle Thomas James's latest insider trade?

disposed of 4.61K shares of $KURA on Sep 28, 2026 at $10.50.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.